CEO Cheoljun Kim Increases Stake through Open Market Purchase, Ownership Rises Slightly

TDSPHARM CEO Cheoljun Kim acquired 2,476 shares at approximately 10,814 KRW per share on June 19, 2026 through open market purchase.
His total holdings increased to 2,542,323 shares, raising his ownership ratio from 45.93% to 45.97%.
This small acquisition is minimal but can be interpreted as a positive signal of management confidence, though its impact on share price is limited.
[AI Summary]The insider's small share purchase slightly increases his stake, signaling management confidence but not materially affecting shareholder value.